Cel-Sci Corporation ($0.001 Par Value) (CVM)

3.52 -0.21 (-5.63%)

IEX Real-Time Price

October 19, 2018 EST.

NYSE American : Healthcare

Prev Close 3.73

Price Open 3.82

Volume: 337,857

Avg Volume: 933,417

Market Cap: 96.28M

P/E Ratio -1.98

52 Wk Range 0.8165-4.44



CVM Short Interest Statistics


Report Date
Float Share
Short Interest
Short Ratio
Short % to Float

2018-09-28
25.01M
1.9M
0.93
7.62%

2018-09-14
25.01M
2.47M
1.17
9.89%

2018-08-31
22.2M
2.66M
2.15
11.99%

2018-08-15
21.2M
1.18M
3.42
5.55%




CVM Earning Report


Report Date
Fiscal Period
Announce Time
Estimated EPS(#)
Actual EPS
Surprise Dollar

2018-08-14
Q3 2018
N/A
0.00 (0)
-0.36
0.00

2018-05-15
Q2 2018
N/A
0.00 (0)
-0.31
0.00

2018-02-12
Q1 2018
N/A
0.00 (0)
-0.53
0.00

2017-12-29
Q4 2017
N/A
0.00 (0)
-0.58
0.00

News

CEL-SCI Announces Warrants to Expire on October 11, 2018 (2018-09-28 08:00 Business Wire)

CEL-SCI Corporation (NYSE American: CVM) is advising the holders of its publicly traded warrants (NYSE American: CVM WS) that the warrants will expire and not be exercisable after 5:00 p.m., New York City time, on October 11, 2018. The NYSE has notified CEL-SCI that trading in the warr…

 


Statistics

Shares Outstanding: 27.35M

Top 15 Institution Percent: 7.40

Price To Sales: 291.46

Price To Book: 5.93

Revenue: 113897

Gross Profit: N/A

Cash: 2.14M

Debt: 14.13M

Return On Assets: -145.78

Return On Equity: 669.65

Profit Margin: N/A

Price History

Beta: 0.49

50-day Moving Avg: 3.05

200-day Moving Avg: 2.23

YTD Change: 89.25

5-day Change: -4.61

1-month Change: -7.61

3-month Change: N/A

6-month Change: 88.24

1-year Change: 96.65

Revenue Per Share: 0.00

Revenue Per Employee: 2589.00



Dividend

Dividend Yield: -

EX-Dividend Date: -

Dividend Rate: -


Company Profile

Name: Cel-Sci Corporation ($0.001 Par Value)

Exchange: NYSE American

Industry: Biotechnology

Sector: Healthcare

Website: http://www.cel-sci.com

CEL-SCI Corp is a biotechnology company. It is engaged in the research and development directed at improving the treatment of cancer and other diseases by utilizing the immune system, the body's natural defense system.